RemSleep Holdings Inc. Files Annual Report on Form 10-K

TL;DR

<b>RemSleep Holdings Inc. has filed its 2023 annual report on Form 10-K, detailing its corporate information and compliance with SEC filing requirements.</b>

AI Summary

RemSleep Holdings Inc. (RMSL) filed a Annual Report (10-K) with the SEC on April 16, 2024. RemSleep Holdings Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2023. The company is incorporated in Nevada and its principal executive offices are located in Clearwater, Florida. RemSleep Holdings Inc. was formerly known as OBICOM, INC., Kat Gold Holdings Corp., and Bella Viaggio, Inc. The company's common stock is registered under Section 12(g) of the Exchange Act. RemSleep Holdings Inc. has submitted all required reports for the preceding 12 months and has been subject to filing requirements for the past 90 days.

Why It Matters

For investors and stakeholders tracking RemSleep Holdings Inc., this filing contains several important signals. This filing provides a comprehensive overview of RemSleep Holdings Inc.'s financial and operational status for the fiscal year 2023, which is crucial for investors to assess the company's performance and outlook. As a smaller reporting company, this 10-K filing is essential for stakeholders to understand RemSleep's compliance with regulatory obligations and its corporate structure, including its history of name changes.

Risk Assessment

Risk Level: low — RemSleep Holdings Inc. shows low risk based on this filing. The filing is a standard 10-K report, indicating routine compliance and no immediate red flags, thus posing a low risk.

Analyst Insight

Review the full 10-K filing for detailed financial statements and management's discussion and analysis to understand RemSleep Holdings Inc.'s performance and future prospects.

Key Numbers

• 2023 — Fiscal Year End (The report covers the fiscal year ended December 31, 2023.)
• 1231 — Fiscal Year End (The company's fiscal year ends on December 31.)
• 000-53450 — Commission File Number (The SEC file number for RemSleep Holdings, Inc.)
• 47-5386867 — IRS Employer Identification No. (The company's IRS EIN.)

Key Players & Entities

• RemSleep Holdings Inc. (company) — Filer name
• 2023 (date) — Fiscal year end
• December 31, 2023 (date) — Fiscal year ended
• Nevada (jurisdiction) — State of incorporation
• Clearwater, Florida (location) — Principal executive offices
• OBICOM, INC. (company) — Former company name
• Kat Gold Holdings Corp. (company) — Former company name
• Bella Viaggio, Inc. (company) — Former company name

FAQ

Industry Context

RemSleep Holdings Inc. operates within the personal services sector, as indicated by its SIC code 7200. This sector encompasses a wide range of service-oriented businesses.

Regulatory Implications

The company is subject to the reporting requirements of the Securities Exchange Act of 1934, including the filing of annual reports on Form 10-K.

What Investors Should Do

1. Review the full Form 10-K for detailed financial statements and disclosures.
2. Analyze the Management's Discussion and Analysis section for insights into the company's operations and strategy.
3. Check for any exhibits or schedules attached to the 10-K that may provide further information.

Year-Over-Year Comparison

This is the annual report for the fiscal year ended December 31, 2023. Previous filings would provide comparative data.

Key Financial Figures

• $0.001 — g) of the Exchange Act: Common Stock, $0.001 par value (Title of class) Indicate
• $7.96 billion — t for sleep treatment and equipment was $7.96 billion in 2011 and continues to increase, with
• $2.7 — asis in the United States. Spending was $2.7 trillion in 2011 and, in 2013, it reach
• $3.6 — n in 2011 and, in 2013, it reached over $3.6 trillion. By 2022, spending was project
• $5 — y 2022, spending was projected to reach $5 trillion, or around 20% of GDP, accordi
• $93 billion — will grow an estimated 2.2% in 2014 to $93 billion. This includes R&D spending, with growt
• $19.72 billion — lion in 2011 and will reach a projected $19.72 billion by 2017, according to a study from Mark
• $7 billion — inesses have combined annual revenue of $7 billion and have maintained a combined annual g
• $3.8 — . "Annual U.S. Healthcare Spending Hits $3.8 Trillion." Feb. 2, 2014. http://www.for
• $59 billion — inesses with combined annual revenue of $59 billion. The market includes medical and skille

Filing Documents

• ea0203609-10k_remsleep.htm (10-K) — 583KB
• ea020360901ex31-1_rem.htm (EX-31.1) — 8KB
• ea020360901ex32-1_rem.htm (EX-32.1) — 4KB
• image_001.jpg (GRAPHIC) — 4KB
• image_002.jpg (GRAPHIC) — 2KB
• 0001213900-24-033498.txt (&nbsp;) — 3585KB
• rmsl-20231231.xsd (EX-101.SCH) — 33KB
• rmsl-20231231_cal.xml (EX-101.CAL) — 34KB
• rmsl-20231231_def.xml (EX-101.DEF) — 191KB
• rmsl-20231231_lab.xml (EX-101.LAB) — 320KB
• rmsl-20231231_pre.xml (EX-101.PRE) — 184KB
• ea0203609-10k_remsleep_htm.xml (XML) — 271KB

Risk Factors

Risk Factors 7 Item 1B. Unresolved Staff Comments 7 Item 1C. Cybersecurity 7 Item 2.

Properties

Properties 8 Item 3.

Legal Proceedings

Legal Proceedings 8 Item 4. Mine Safety Disclosures 8 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 9 Item 6. [Reserved] 9 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 9 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 11 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data F-1 Item 9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosure 12 Item 9A.

Controls and Procedures

Controls and Procedures 12 Item 9B. Other Information 13 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. 13 PART III Item 10. Directors, Executive Officers, and Corporate Governance 14 Item 11.

Executive Compensation

Executive Compensation 15 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 16 Item 13. Certain Relationships and Related Transactions, and Director Independence 16 Item 14. Principal Accountant Fees and Services 17 PART IV Item 15. Exhibits and Financial Statement Schedules 18 Item 16. Form 10-K Summary 18

Signatures

Signatures 19 i PART I

DESCRIPTION OF BUSINESS

ITEM 1. DESCRIPTION OF BUSINESS

Forward Looking Statements

Forward Looking Statements Except for statements of historical fact, the information presented herein constitutes forward-looking statements. These forward-looking statements generally can be identified by phrases such as "anticipates," "believes," "estimates," "expects," "forecasts," "foresees," "intends," "plans," or other words of similar import. Similarly, statements herein that describe our business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, our ability to: successfully commercialize our technology; generate revenues and achieve profitability in an intensely competitive industry; compete in products and prices with substantially larger and better capitalized competitors; secure, maintain and enforce a strong intellectual property portfolio; attract additional capital sufficient to finance our working capital requirements, as well as any investment of plant, property and equipment; develop a sales and marketing infrastructure; identify and maintain relationships with third party suppliers who can provide us a reliable source of raw materials; acquire, develop, or identify for our own use, a manufacturing capability; attract and retain talented individuals; continue operations during periods of uncertain general economic or market conditions, and; other events, factors and risks previously and from time to time disclosed in our filings with the Securities and Exchange Commission, including, specifically, the "Risk Factors" enumerated herein. Although we believe the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee future results,

View Full Filing

View this 10-K filing on SEC EDGAR